Expert says drugs should be last resort for quitting

The Cochrane Review of nicotine receptor partial agonists for smoking cessation found that the standard dosage of varenicline (Champix, Pfizer) increased the chances of successful cessation at six months more than twofold, compared to placebo, with nausea the main adverse event. 

But anti-tobacco campaigner Simon Chapman, professor of public health at the University of Sydney, called for better education for doctors in alternatives to pharmacological treatment, saying clinical trial results were often not relevant to the ‘real world’.

“There is a massive push to get as many smokers to use